Physiologically Based Pharmacokinetic Modeling To Guide Management of Drug Interactions between Elexacaftor-Tezacaftor-Ivacaftor and Antibiotics for the Treatment of Nontuberculous... von Hong, E, Almond, L M, Chung, P S, Rao, A P, Beringer, P M

Volltext

Subregional laminar cartilage MR spin–spin relaxation times (T2) in osteoarthritic knees with and without medial femorotibial cartilage loss – data from the Osteoarthritis Initiati... von Wirth, W, Maschek, S, Beringer, P, Eckstein, F

Volltext

EPS7.4 Sub-inhibitory anti-staphylococcal antibiotics differentially modulate fibronectin binding protein-induced adhesion in Staphylococcus aureus isolates from adult cystic fibro... von Algorri, M, Trinh, K, Beringer, P, She, R, Wong-Beringer, A

Volltext

Change in cartilage T2 relaxation time in osteoarthritic knees with and without structural progression – Pilot data from the osteoarthritis initiative von Wirth, W, Maschek, S, Beringer, P, Eckstein, F

Volltext

175 Pharmacokinetics of ceftazidime-avibactam in adults with CF von Beringer, P, Bensman, T, Wang, J, Fukushima, L, D'Argenio, D.Z, Rao, A.P

Volltext

The clinical use of colistin in patients with cystic fibrosis von Beringer, Paul

Volltext

WS7.2 Antibacterial activity of theta defensin (RTD-1) against clinical isolates of Pseudomonas aeruginosa von Beringer, P, Ho, H, Bensman, T, Nguyen, A, Wong-Beringer, A, Selsted, M

Volltext

Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials von AMINIMANIZANI, Amir, BERINGER, Paul, JELLIFFE, Roger

Volltext

492 Evaluation of elexacaftor/tezacaftor/ivacaftor dosing guidance in cystic fibrosis-associated liver disease using physiologically based pharmacokinetic modeling von Shi, A., Hong, E., Chung, P., Rao, A., Beringer, P.

Volltext

495 Pharmacokinetics of omadacycline in adults with cystic fibrosis von Sanders, M., Hong, E., Chung, P., Rao, A., Beringer, P.

Volltext

494 Pharmacokinetics of elexacaftor/tezacaftor/ivacaftor with concomitant rifabutin von Sanders, M., Hong, E., Chung, P., Rao, A., Beringer, P.

Volltext

242: Evaluation of the drug-drug interaction potential of clofazimineivacaftor using a physiologically based pharmacokinetic simulation approach von Hong, E., Rao, A., Beringer, P.

Volltext

423 Evaluation of the drug-drug interaction potential of elexacaftorrosuvastatin using a physiologically based pharmacokinetic simulation approach von Shi, A., Beringer, P., Hong, E., Rao, A., Chung, P.

Volltext

Population Pharmacokinetics and Use of Monte Carlo Simulation To Evaluate Currently Recommended Dosing Regimens of Ciprofloxacin in Adult Patients with Cystic Fibrosis von MONTGOMERY, Megan J, BERINGER, Paul M, AMINIMANIZANI, Amir, LOUIE, Stan G, SHAPIRO, Bertrand J, JELLIFFE, Roger, GILL, Mark A

Volltext

Pharmacokinetics of Tobramycin in Adults with Cystic Fibrosis: Implications for Once-Daily Administration von BERINGER, P. M, VINKS, A. A. T. M. M, JELLIFFE, R. W, SHAPIRO, B. J

Volltext

Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis von Aminimanizani, A., Beringer, P. M., Kang, J., Tsang, L., Jelliffe, R. W., Shapiro, B. J.

Volltext

182: Treatment of airway hyperreactivity in patients with cystic fibrosis von Craver, K., Beringer, P., Lester, M., Rao, A.

Volltext

Stability and Antibacterial Activity of Cefepime during Continuous Infusion von SPRAUTEN, Pal F, BERINGER, Paul M, LOUIE, Stan G, SYNOLD, Timothy W, GILL, Mark A

Volltext

Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features von Beringer, Paul M, Appleman, Maria D

Volltext

Absolute Bioavailability and Pharmacokinetics of Linezolid in Hospitalized Patients Given Enteral Feedings von BERINGER, Paul, NGUYEN, Megan, HOEM, Nils, LOUIE, Stan, GILL, Mark, GUREVITCH, Michael, WONG-BERINGER, Annie

Volltext